Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers

André C Schmidt1 Charité – Universitätsmedizin Berlin, Institute for Clinical Pharmacology and Toxikology, Berlin, GermanyCorrespondence[email protected]

Burkhard Flick1 Charité – Universitätsmedizin Berlin, Institute for Clinical Pharmacology and Toxikology, Berlin, Germany

Elke Jahn2 Berlin-Chemie AG, Clinical Research and Medical Information, Berlin, Germany

Peter Bramlage3 Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany

Pages 909-915 | Published online: 24 Dec 2022

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

AblijHMeindersA2002C-reactive protein: history and revivalEur J Intern Med1341212384129
PubMedGoogle Scholar
BlakeGJRidkerPM2002Inflammatory bio-markers and cardiovascular risk predictionJ Intern Med2522839412366601
PubMed Web of Science ®Google Scholar
BroedersMADoevendansPABekkersBC2000Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta2-adrenergic receptor-mediated nitric oxide productionCirculation1026778410931809
PubMed Web of Science ®Google Scholar
BrunnerHCockcroftJRDeanfieldJ2005Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of HypertensionJ Hypertens232334615662207
PubMed Web of Science ®Google Scholar
CaiHHarrisonDG2000Endothelial dysfunction in cardiovascular diseases: the role of oxidant stressCirc Res87840411073878
PubMed Web of Science ®Google Scholar
CelermajerDSSorensenKEGeorgakopoulosD1993Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adultsCirculation882149558222109
PubMed Web of Science ®Google Scholar
CockcroftJ2004Nebivolol: a reviewExpert Opin Pharmacother5893915102571
PubMed Web of Science ®Google Scholar
CockcroftJRChowienczykPJBrettSE1995Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanismJ Pharmacol Exp Ther2741067717562470
PubMed Web of Science ®Google Scholar
EaglesCJMartinU1998Non-pharmacological modification of cardiac risk factors: part 3. Smoking cessation and alcohol consumptionJ Clin Pharm Ther23199756105
PubMed Web of Science ®Google Scholar
EsenAMBarutcuIAcarM2004Effect of smoking on endothelial function and wall thickness of brachial arteryCirc J681123615564694
PubMed Web of Science ®Google Scholar
FichtlschererSZeiherAM2000Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levelsAnn Med32515811127928
PubMed Web of Science ®Google Scholar
KaoPCShieshSCWuTJ2006Serum C-reactive protein as a marker for wellness assessmentAnn Clin Lab Sci36163916682512
PubMed Web of Science ®Google Scholar
LekakisJPProtogerouAPapamichaelC2005Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery diseaseCardiovasc Drugs Ther192778116187009
PubMed Web of Science ®Google Scholar
LindLSarabiMMillgardJ2003The effect of smoking on endothelial vasodilatory function evaluated by local infusion of metacholine in the forearm is dependent on the duration of smokingNicotine Tob Res51253012745514
PubMed Web of Science ®Google Scholar
LuJTCreagerMA2004The relationship of cigarette smoking to peripheral arterial diseaseRev Cardiovasc Med51899315580157
PubMedGoogle Scholar
LuscherTFNollG1996Endothelial function as an end-point in interventional trials: concepts, methods and current dataJ Hypertens Suppl14S1119discussion S119–21.8934387
PubMedGoogle Scholar
LuscherTFSpiekerLENollG2001Vascular effects of newer cardiovascular drugs: focus on nebivolol and ACE-inhibitorsJ Cardiovasc Pharmacol38Suppl 3S31111811390
PubMedGoogle Scholar
MarchesiSLupattelliGLombardiniR2005Acute inflammatory state during influenza infection and endothelial functionAtherosclerosis1783455015694944
PubMed Web of Science ®Google Scholar
MoncadaSHiggsEA2006The discovery of nitric oxide and its role in vascular biologyBr J Pharmacol147Suppl 1S19320116402104
PubMed Web of Science ®Google Scholar
RoddieICWallaceWF1979Methods for the assessment of the effects of drugs on the arterial system in manBr J Clin Pharmacol731723375956
PubMed Web of Science ®Google Scholar
SarabiMLindL2000Short-term effects of smoking and nicotine chewing gum on endothelium-dependent vasodilation in young healthy habitual smokersJ Cardiovasc Pharmacol35451610710132
PubMed Web of Science ®Google Scholar
SchmidtACGrafCBrixiusK2007Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO studyClin Drug Investig278419
PubMed Web of Science ®Google Scholar
VermaSSzmitkoPERidkerPM2005C-reactive protein comes of ageNat Clin Pract Cardiovasc Med22936quiz 58.16265340
PubMedGoogle Scholar
VyssoulisGPMarinakisAGAznaouridisKA2004The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smokingAm J Hypertens17582915233977
PubMed Web of Science ®Google Scholar
WhitneyRJ1953The measurement of volume changes in human limbsJ Physiol12112713085295
PubMed Web of Science ®Google Scholar
WillersonJTRidkerPM2004Inflammation as a cardiovascular risk factorCirculation109II21015173056
PubMed Web of Science ®Google Scholar
WilsonAMRyanMCBoyleAJ2006The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogenInt J Cardiol106291716337036
PubMed Web of Science ®Google Scholar
ZhangWZVenardosKChin-DustingJ2006Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stressHypertension482788516801489
PubMed Web of Science ®Google Scholar
ZoccaliC2006Asymmetric dimethylarginine ADMA.: a cardiovascular and renal risk factor on the moveJ Hypertens24611916531785
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date